148 related articles for article (PubMed ID: 33323673)
1. Computational Identification of Essential Enzymes as Potential Drug Targets in
Narad P; Himanshu ; Bansal H
J Microbiol Biotechnol; 2021 Apr; 31(4):621-629. PubMed ID: 33323673
[No Abstract] [Full Text] [Related]
2. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Identification of Potential Drug Target in Enterobacteriaceae Family: A Homology-Based Method.
Hadizadeh M; Tabatabaiepour SN; Tabatabaiepour SZ; Hosseini Nave H; Mohammadi M; Sohrabi SM
Microb Drug Resist; 2018; 24(1):8-17. PubMed ID: 28520499
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors that target bacterial virulence identified via HTS against intra-macrophage survival of
Miljkovic M; Lozano S; Castellote I; de Cózar C; Villegas-Moreno AI; Gamallo P; Jimenez-Alfaro Martinez D; Fernández-Álvaro E; Ballell L; Garcia GA
mSphere; 2023 Oct; 8(5):e0015423. PubMed ID: 37565760
[No Abstract] [Full Text] [Related]
5. An Approach for Identification of Novel Drug Targets in Streptococcus pyogenes SF370 Through Pathway Analysis.
Singh S; Singh DB; Singh A; Gautam B; Ram G; Dwivedi S; Ramteke PW
Interdiscip Sci; 2016 Dec; 8(4):388-394. PubMed ID: 26750924
[TBL] [Abstract][Full Text] [Related]
6. An in silico hierarchal approach for drug candidate mining and validation of natural product inhibitors against pyrimidine biosynthesis enzyme in the antibiotic-resistant Shigella flexneri.
Basharat Z; Khan K; Jalal K; Ahmad D; Hayat A; Alotaibi G; Al Mouslem A; Aba Alkhayl FF; Almatroudi A
Infect Genet Evol; 2022 Mar; 98():105233. PubMed ID: 35104682
[TBL] [Abstract][Full Text] [Related]
7. Cardiolipin Synthesis and Outer Membrane Localization Are Required for
Rossi RM; Yum L; Agaisse H; Payne SM
mBio; 2017 Aug; 8(4):. PubMed ID: 28851846
[TBL] [Abstract][Full Text] [Related]
8. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
León Y; Zapata L; Salas-Burgos A; Oñate A
Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
[TBL] [Abstract][Full Text] [Related]
9. Finding Potential Therapeutic Targets against
Hossain MU; Khan MA; Hashem A; Islam MM; Morshed MN; Keya CA; Salimullah M
Front Microbiol; 2016; 7():1817. PubMed ID: 27920755
[No Abstract] [Full Text] [Related]
10. Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum β-lactamase (ESBL).
Shen P; Fan J; Guo L; Li J; Li A; Zhang J; Ying C; Ji J; Xu H; Zheng B; Xiao Y
Ann Clin Microbiol Antimicrob; 2017 May; 16(1):37. PubMed ID: 28499446
[TBL] [Abstract][Full Text] [Related]
11. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
[TBL] [Abstract][Full Text] [Related]
12. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
[TBL] [Abstract][Full Text] [Related]
13. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
14. Formate Promotes
Koestler BJ; Fisher CR; Payne SM
mBio; 2018 Sep; 9(5):. PubMed ID: 30254126
[TBL] [Abstract][Full Text] [Related]
15. Newly Emerged Serotype 1c of
Parajuli P; Minh BQ; Verma NK
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899396
[TBL] [Abstract][Full Text] [Related]
16. Differences in tetracycline resistance determinant carriage among Shigella flexneri and Shigella sonnei are not related to different plasmid Inc-type carriage.
Pons MJ; Torrents de la Peña A; Mensa L; Martón P; Ruiz-Roldán L; Martínez-Puchol S; Vila J; Gascón J; Ruiz J
J Glob Antimicrob Resist; 2018 Jun; 13():131-134. PubMed ID: 29307861
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri.
McCloskey MC; Shaheen S; Rabago L; Hulverson MA; Choi R; Barrett LK; Arnold SLM
Sci Rep; 2019 Sep; 9(1):13567. PubMed ID: 31537849
[TBL] [Abstract][Full Text] [Related]
18. Dissemination of Multidrug-Resistant
Kang H; Wang L; Li Y; Lu Y; Fan W; Bi R; Qian H; Gu B
Microb Drug Resist; 2019 Dec; 25(10):1465-1474. PubMed ID: 31369341
[No Abstract] [Full Text] [Related]
19. Designing and evaluation of an antibody-targeted chimeric recombinant vaccine encoding Shigella flexneri outer membrane antigens.
Kazi A; Hisyam Ismail CMK; Anthony AA; Chuah C; Leow CH; Lim BH; Banga Singh KK; Leow CY
Infect Genet Evol; 2020 Jun; 80():104176. PubMed ID: 31923724
[TBL] [Abstract][Full Text] [Related]
20. Shigella flexneri: an emerging pathogen.
Nisa I; Qasim M; Yasin N; Ullah R; Ali A
Folia Microbiol (Praha); 2020 Apr; 65(2):275-291. PubMed ID: 32026288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
